Crinetics Pharmaceuticals
CRNX
CRNX
122 hedge funds and large institutions have $948M invested in Crinetics Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $885M → $948M (+$63.3M)
1.4% more ownership
Funds ownership: 94.65% → 96.05% (+1.4%)
Holders
122
Holding in Top 10
7
Calls
$2.51M
Puts
–
Top Buyers
| 1 | +$15.9M | |
| 2 | +$10.2M | |
| 3 | +$8.94M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$7.46M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.09M |
Top Sellers
| 1 | -$21M | |
| 2 | -$6M | |
| 3 | -$3.83M | |
| 4 |
Millennium Management
New York
|
-$3.68M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.07M |